{"id":6928,"date":"2026-05-04T15:53:49","date_gmt":"2026-05-04T10:23:49","guid":{"rendered":"https:\/\/nervnow.com\/?p=6928"},"modified":"2026-05-04T15:54:04","modified_gmt":"2026-05-04T10:24:04","slug":"carlyle-closes-dual-rcm-deal-with-knack-rcm-and-equalizercm","status":"publish","type":"post","link":"https:\/\/nervnow.com\/ro\/carlyle-closes-dual-rcm-deal-with-knack-rcm-and-equalizercm\/","title":{"rendered":"Carlyle Closes Dual RCM Deal With Knack RCM and EqualizeRCM"},"content":{"rendered":"

The combined platform will use AI-driven automation to serve hospital groups, rural clinics, and specialty practices across the United States.<\/strong><\/em><\/p>\n\n\n\n

The Carlyle Group has acquired Knack RCM and EqualizeRCM, combining two U.S.-based revenue cycle management companies into a single AI-native platform targeting multi-specialty healthcare providers globally. Carlyle’s majority stake in Knack Global, the parent company of Knack RCM, was valued at approximately $500 million. Financial terms of the EqualizeRCM transaction were not disclosed.<\/p>\n\n\n\n

Knack RCM, founded in 2007 and headquartered in Florida, provides end-to-end revenue cycle services including medical billing and coding, durable medical equipment billing, credentialing, and accounts receivable management. The company uses AI-driven automation alongside global delivery teams, serving hospital groups, physician practices, and ambulatory care centers. <\/p>\n\n\n\n

EqualizeRCM, based in Austin, Texas, focuses on small to mid-sized hospitals, federally qualified health centers, rural health clinics, and specialty practices across dental, DME, and behavioral health.<\/p>\n\n\n\n

ALSO READ: Linkerbot Eyes $6B Valuation, Double Its Latest $3B Mark<\/a><\/strong><\/p>\n\n\n\n

The two companies serve complementary segments of the U.S. provider market. Knack RCM’s client base skews toward larger, multi-site hospital and physician group clients. EqualizeRCM has built its base among critical access hospitals and rural providers, a segment facing mounting financial pressure. Under Carlyle’s ownership, the combined operation spans the full U.S. provider market with delivery infrastructure across domestic and offshore locations.<\/p>\n\n\n\n

The deal arrives as private equity consolidation in healthcare RCM accelerates sharply. Blackstone acquired AGS Health for $1.1 billion, and Waystar announced a $1.25 billion acquisition of Iodine Software, positioning AI-enabled revenue cycle management as one of the most actively contested segments in healthcare services investment. <\/p>\n\n\n\n

Carlyle itself held a majority stake in CorroHealth, another technology-driven RCM company, since 2019, giving the firm deep institutional knowledge of the sector before this latest move.<\/p>\n\n\n\n

U.S. healthcare providers lose an estimated $440 billion annually to administrative costs, a figure that has made revenue cycle management an increasingly attractive target for capital looking to deploy AI automation at scale.<\/p>\n\n\n\n

Disclaimer: This news is based on publicly available information. NervNow has not independently verified the details.<\/em><\/strong>

MORE ON AI FUNDINGS & STARTUPS<\/strong>
Planet Labs Launches 3 AI-Powered Pelican Satellites Into Orbit<\/a>
Nebius to Acquire Eigen AI for $643M, Eyes AI Infrastructure Growth<\/a>
Avoca Raises $125M Series B, Hits Unicorn Status<\/a>
Portkey Heads to Palo Alto Networks in Latest India-to-Global AI Exit<\/a><\/p>","protected":false},"excerpt":{"rendered":"

The dual acquisition gives Carlyle a combined RCM operation covering hospital groups, physician practices, rural health clinics, federally qualified health centers, and DME providers across the US.<\/p>","protected":false},"author":2,"featured_media":6929,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_gspb_post_css":"","om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[103,94],"tags":[196,84],"class_list":["post-6928","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ai-now","category-news","tag-global","tag-just-in"],"blocksy_meta":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/posts\/6928","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/comments?post=6928"}],"version-history":[{"count":2,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/posts\/6928\/revisions"}],"predecessor-version":[{"id":6932,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/posts\/6928\/revisions\/6932"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/media\/6929"}],"wp:attachment":[{"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/media?parent=6928"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/categories?post=6928"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/tags?post=6928"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}